Which hedge funds own ANRO? ALTO NEUROSCIENCE INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in ANRO (ALTO NEUROSCIENCE INC) in their Q2 2026 13F filings, worth $136.4m in total. The largest holder by portfolio weight is Falcon Edge Capital at 1.6% of its book. 3 exited: Brevan Howard Capital Management, D. E. Shaw & Co, Polen Capital Management.
6tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold ANRO? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Falcon Edge Capital | Q2 2026 | 1.6% | $97.8m | 3,707,757 | 0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $13.3m | 502,950 | -0% | held |
| Alkeon Capital Management | Q2 2026 | 0.0% | $2.7m | 102,101 | -55% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $14.7m | 558,320 | -32% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $6.0m | 225,503 | 28% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $1.9m | 71,399 | -31% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.1% | $871.8k |
| D. E. Shaw & Co | 0.0% | $1.0m |
| Polen Capital Management | 0.4% | $373.5k |
How has hedge fund ownership of ANRO changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $136.4m |
| Q1 2026 | 9 | $126.8m |
| Q4 2025 | 4 | $104.8m |
| Q3 2025 | 4 | $22.5m |
| Q2 2025 | 4 | $12.2m |
| Q1 2025 | 4 | $12.5m |
| Q4 2024 | 4 | $27.5m |
| Q3 2024 | 6 | $92.2m |
| Q2 2024 | 5 | $84.5m |
| Q1 2024 | 4 | $97.4m |
Counts every tracked manager that disclosed ANRO in that quarter's filing, including managers that have since stopped filing.